Furosemide Tablet
Product Images NDC 71610-951

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 71610-951). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0951 45)

Furosemide USP 40 mg oral tablet label showing 45 tablets per container. The label includes storage instructions to keep between 20-25 degrees Celsius and dispense in a tight light-resistant container. Manufactured by Leading Pharma, LLC in Fairfield, NJ, and repackaged by Aphena Pharma, Cookeville, TN. Includes NDC 71610-951-45 and indicates prescription use only.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Furosemide Structure (Furosemide Image01)

Chemical structure of Furosemide, showing its molecular components including a chlorinated aromatic ring, sulfonamide group, carboxylic acid group, and a furan ring connected by an ether linkage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.